How to Cite
Abstract
According to the cancer register in Novosibirsk for the period of 1988-2012 there were studied the incidence and mortality from cancer of the colon and rectum. For rectal cancer indicators declined slightly but similar rates for colon cancer remained highly stable. While the rate of detection of stage III-IV colorectal cancer decreased by one third. Men exposed to colorectal cancer more often than women, especially in the older age groups, while there were differences between cancer of the colon and rectum. The authors discuss possibilities of control over the incidence of colorectal cancer. Screening is currently optimal, which includes non-invasive analysis of the fecal samples and colonoscopy that allows diagnosing precancerous colon lesions and early cancer.References
Злокачественные новообразования в России в 2012 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России, 2014. - 250 с.
Имянитов Е.Н. Клинико-молекулярные аспекты колоректального рака: этиопатогенез, профилактика, индивидуализация лечения // Практическая онкология. - 2005. - № 2. - C. 65-70.
Петерсон Б.Е. Онкология / М.: Медицина, 1980. - 448 с.
Ahlquist D.A., Zou H., Domanico M. et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas // Gastroenterology. - 2012. - Vol. 142. - P. 248-256.
Boyle P., Leon M.E. Epidemiology of colorectal cancer // British Medical Bulletin. - 2002. - Vol. 64. - P. 1-25.
Burch J.A., Soares-Weiser К., St John D.J.B. et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review // J. Med Screen. - 2007. - Vol. 14. - P. 132-137.
Cancer Incidence in Five Continents Vol. VIII., IARC Scientific Publication No. 155, Edited by D.M. Parkin, S.L. Whelan, J. Ferlay, L. Teppo and D.B. Thomas, 2013.
Davies R.J., Miller R., Coleman N. Colorectal cancer screening: prospects for molecular stool analysis // Nat. Rev. Cancer. -2005. - Vol. 5. - P. 199-209.
Dinh T., Ladabaum U., Alperin P. et al. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer // Clin Gastroenterol Hepatol. - 2013. - Vol. 11 (9). - P. 1158-1166.
Ferlay J., Shin H.R., Bray F. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 // Int J. Cancer. - 2010. - Vol. 127 (12). - P. 2893-2917.
Kuipers E.J., Rösch T., Bretthauer M. Colorectal cancer screening - optimizing current strategies and new directions // Nat Rev Clin Oncol. - 2013. - 10 (3). - P. 130-142.
Levell N.J., Igali L., Wright K.A., Greenberg D.C. Basal cell carcinoma epidemiology in the UK: the elephant in the room // Clin Exp Dermatol. - 2013. - Vol. 38. - P. 367-369.
Pericleous М., Mandair D., Caplin M.E. Diet and supplements and their impact on colorectal cancer // J. Gastrointest Oncol. - 2013. - Vol. 4 (4). - P. 409-423.
Siegel R., Desantis C., Jemal A. Colorectal cancer statistics, 2014 // CA Cancer J. Clin. - 2014. - Vol. 64 (2). - P. 104-117.
WGO Practice Guidelines 2008. Практическое руководство Всемирного гастроэнтерологического общества (ВГО) и Международного союза по профилактике рака пищеварительной системы: Скрининг колоректального рака.World Gastroenterology Organisation, 2008.
Wynford D., Thomas J., Blaydes J. The influence of cell context on the selection pressure for p53 mutation in human cancer // Carcinogenesis. - 1998. - Vol. 191. - P. 29-36.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...